Cart 0

Tumor Microenvironment and Cancer Immunity

The tumor microenvironment (TME) represents the intricate milieu surrounding a tumor, comprising various cellular and non-cellular components that intricately interact with cancer cells. This dynamic and multifaceted environment exerts a profound influence on tumor progression, metastasis, and response to therapy. The TME is a complex network of immune cells, fibroblasts, blood vessels, extracellular matrix components, and signaling molecules, collectively orchestrating a supportive or inhibitory landscape for the tumor.

Within the TME, specific protein markers play crucial roles in modulating tumor behavior and are often indicative of the immune response, angiogenesis, and extracellular matrix composition.

Some notable protein markers specific to the TME include:

PD-L1 (Programmed Death-Ligand 1): PD-L1 is expressed on the surface of tumor cells and immune cells within the TME. Its interaction with PD-1 on immune cells can suppress the immune response, facilitating immune evasion by the tumor.

TGF-β (Transforming Growth Factor-beta): TGF-β is a multifunctional cytokine in the TME that regulates processes such as cell proliferation, differentiation, and immune response. Its dysregulation contributes to the immunosuppressive nature of the TME.

VEGF (Vascular Endothelial Growth Factor): VEGF is a key protein involved in angiogenesis within the TME. It promotes the formation of new blood vessels, supporting tumor growth and providing a route for metastatic spread.

Granzyme B: Granzyme B is an enzyme released by cytotoxic T cells and natural killer cells within the TME. Its presence reflects the cytotoxic activity of the immune response against tumor cells.

Understanding the intricate interplay between these protein markers and the TME is crucial for developing targeted therapies that aim to manipulate the tumor microenvironment to enhance anti-tumor immune responses or disrupt supportive factors for tumor growth.

Download the "Tumor Microenvironment and Cancer Immunity" white paper:

DOWNLOAD WHITE PAPER
 

Anti-KIT Antibody
Anti-KIT Antibody

Anti-KIT Antibody

AMAb90904
In Stock (10+)
3 490,0 kr
Anti-PDCD1 Antibody
Anti-PDCD1 Antibody

Anti-PDCD1 Antibody

AMAb91197
In Stock (10+)
3 490,0 kr
Anti-RGS5 Antibody

Anti-RGS5 Antibody

AMAb91377
In Stock (10+)
4 352,0 kr
Anti-TNFRSF18 Antibody

Anti-TNFRSF18 Antibody

AMAb91487
In Stock (10+)
4 106,0 kr
Anti-CD44 Antibody
Anti-CD44 Antibody

Anti-CD44 Antibody

HPA005785
In Stock (10+)
3 490,0 kr
Anti-PDPN Antibody
Anti-PDPN Antibody

Anti-PDPN Antibody

HPA007534
In Stock (10+)
4 106,0 kr
Anti-PDCD1LG2 Antibody
Anti-PDCD1LG2 Antibody

Anti-PDCD1LG2 Antibody

HPA013411
In Stock (10+)
4 106,0 kr
Anti-IDO1 Antibody
Anti-IDO1 Antibody

Anti-IDO1 Antibody

HPA023072
In Stock (10+)
3 490,0 kr
Anti-FOXP3 Antibody
Anti-FOXP3 Antibody

Anti-FOXP3 Antibody

HPA045943
In Stock (10+)
3 490,0 kr